Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$NVAX #NVAX my buddy at Stocktwit who lives 5 minutes from the Novavax headquarters, had a drink w/ some Novavax employees. They said Stan already filed with the FDA today. So I guess it's just the PR Team awake tonight for the big Press release tomorrow. Hope Stan has TV talk https://t.co/4hjixVVOu5
Congratulations here! Great news! Price will eventually rise
Yes. This will be one of the last buying opportunities. FDA submission coming. Even without it, the sales are starting internationally. Q1 will look great. Q2 will look better. The US (only 330 million population) is helpful but not necessary for massive profitability. This hits $300 soon.
https://mvec.mcri.edu.au/events/
NVAX can be stored and transported in regular refrigerator. Effectiveness as good as Pfizer and Moderna.
Peptide and not genetic material, maybe more acceptable to consumer.
Vaccine sales can surpass Moderna and Pfizer combined!
now $200 plus $nvax
#NVAX European Union approval & WHO listing next week? Time to get in before run? Price analysis
https://www.promegaconnections.com/virus-like-particles-all-the-bark-none-of-the-bite/
https://www.novavax.com/our-unique-technology#recombinant-nanoparticle-vaccine-technology
The future is now. The reality is Novavax!
Nuvaxovid™!
Yes it is.
“Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization”
It's happening!
Special sauce delivery!
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines
Consider the efficacy of Novavax booster vs. Moderna’s…
“…the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Moderna COVID-19 vaccine (mRNA-1273) at the 50 µg dose level…”
Vs. 5 micrograms: https://ir.novavax.com/2021-08-05-Novavax-Announces-COVID-19-Vaccine-Booster-Data-Demonstrating-Four-Fold-Increase-in-Neutralizing-Antibody-Levels-Versus-Peak-Responses-After-Primary-Vaccination
Or 30 micrograms of the Pfizer BioNTech booster.
Novavax Inc (NVAX)
156.9 ? -22.51 (-12.55%)
Volume: 12,458,716 @11/05/21 7:59:59 PM EDT
Bid Ask Day's Range
130.0 156.91 146.11 - 165.9353
NVAX Detailed Quote
$nvax needs to spill more beans
Novavax files for "vacinne" approval with WHO.
Novavax files for "vacinne" approval in New Zealand.
Boy, New Zealand will be thankful for another shot available. I think they have 2 or 3 cases. Hopefully this one will let the kids get some sunshine.
EUA approval in Indonesia. "Vaccine" doses will be shipped as soon as possible.
THIS WEEK...
Novavax files for "vaccine" approval in U.K. and Australia.
Soon to file for approval in EU, New Zealand, + including USA by end of year 2021.
Bullish?
I'm still curious if this shot will prevent transmission and actually kill the virus, unlike any other currently on the market.
So! Here we are looking at the next Covid 19 Vaccine, only this one is coming from the French. They are already manufacturing the Vaccine in Ireland. IMO They will kick some serous *ss. Leave it to the French.
This stock will definitely skyrocket as it already has. Very low float.
Only 49.5M outstanding. On October 18 they announced their phase 3 trials. Vaccine has 95% efficacy and they have already applied to the EU and Great Britain for Regulatory approval.
This vaccine is also Adjuvant and has a long shelf life just like NVAX.
Do your own DD to find the ticker. NASDQ.
NVAX $140 BREAK= $$$
$136.79 hi from $115
Offering is about to come buddy… They are financially tapped out and as usual Nvax is known for offerings and it’s been a LOOOONG time since they done one…
I expect this to go right back up when the truth comes out this is old news about USA manufacturing...Us fda is their lowest priority unfortunately.... This has absolutely nothing to do with all the filings around the world.... Seems suspicious how when we get good news there is always a time hit piece to slow us down
.
$NVAX $120 looking for news
Does this medicine actually kill the virus, prevent infection, or stop the spread of the virus? I think these factors are kinda important to those who are "on the fence" about the current pseudo vaccines on the market.
https://www.yalemedicine.org/news/covid-19-vaccine-comparison
Novavax
This vaccine has been shown to be highly effective in clinical trials. The Novavax vaccine is a protein adjuvant. It is simpler to make than some of the other vaccines and can be stored in a refrigerator, making it easier to distribute. Novovax has studied its vaccine in combination with the influenza vaccine with positive results.
Status: Not available in the U.S. at this time, but could become available in several other countries toward the end of this year and early next year.
Recommended for: The vaccine is being studied in people ages 12-84.
Dosage: 2 doses, three weeks apart
Common side effects: Injection site tenderness, fatigue, headache, muscle pain.
How it works: Unlike the mRNA and vector vaccines, this is a protein adjuvant (an adjuvant is an ingredient used to strengthen the immune response). While other vaccines trick the body’s cells into creating parts of the virus that can trigger the immune system, the Novavax vaccine takes a different approach. It contains the spike protein of the coronavirus itself, but formulated as a nanoparticle, which cannot cause disease. When the vaccine is injected, this stimulates the immune system to produce antibodies and T-cell immune responses.
How well it works: 90% effective against lab-confirmed, symptomatic infection and 100% against moderate and severe disease in Phase 3 trial results released in a company statement in June. The company says the vaccine was 91% protective of people in high-risk populations such as people older than 65, those with health conditions that increase risk of complication, and those in situations where they are frequently exposed to the virus.
How well it works on virus mutations: Novavax says the vaccine is 93% effective against “predominantly circulating variants of concern and variants of interest.” But it’s important to note that the study was conducted in the U.S. and Mexico, when Alpha was the predominant strain in the U.S., although other variants were on the rise. More data is needed to determine the effectiveness of Novavax against the Delta variant.
Note: The COVID-19 vaccines do not change—or interact with—a recipient’s DNA.
Quite a ride from the RS and $4PPS to over $300 and then.... No product on the market and this decline.
It’s time Novavax commes with results so we won’t see this again
Novavax Inc (NVAX)
183.05 ? -24.26 (-11.70%)
Novavax Inc (NVAX)
230.0 ? -0.29 (-0.13%)
Volume: 2,363,197 @09/22/21 7:59:55 PM EDT
Bid Ask Day's Range
229.98 230.25 224.15 - 234.11
NVAX Detailed Quote
$NVAX Scientists continue to say there isn't enough evidence to make COVID-19 boosters available to all Americans
$NVAX Scientists continue to say there isn't enough evidence to support giving COVID-19 boosters to all Americans
U.S. Education Department opens civil-rights probe of school face-mask bans in latest clash between Republican governors and Biden administration $NVAX
Anamnestic responses ahead!
Get it Novavax!
A lot of peeps getting punked & played:
https://m.republicworld.com/technology-news/social-media-news/facebook-suspends-russian-accounts-running-anti-vaccine-campaign-against-astrazeneca.html
Yes. Getting blamed for spreading a disease I don’t have to people who are vaccinated. That’s a first.
?
Followers
|
340
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8607
|
Created
|
06/19/03
|
Type
|
Free
|
Moderators mick JoeForkeyBolo |
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases.
Using innovative proprietary recombinant nanoparticle vaccine technology,
we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...
INVESTORS
Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease. More...
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |